BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Zeng Y, Yu W, Liu Q, Yu WW, Zhu ZF, Zhao WX, Liu J, Wang JM, Fu XL, Liu Y, Cai XW. Difference in failure patterns of pT3-4N0-3M0 esophageal cancer treated by surgery vs surgery plus radiotherapy. World J Gastrointest Oncol 2019; 11(12): 1172-1181 [PMID: 31908722 DOI: 10.4251/wjgo.v11.i12.1172]
URL: https://www.wjgnet.com/1948-5204/full/v11/i12/1172.htm
Number Citing Articles
1
Yichun Wang, Fan Wang. <p>Postoperative Radiotherapy for Thoracic Esophageal Carcinoma with Upfront R0 Esophagectomy</p>Cancer Management and Research 2020; : 13023 doi: 10.2147/CMAR.S286074
2
Jing Cai, Shan Zhou, Yuxi Luo, Anwen Liu. Effect and safety of anlotinib combined with S-1 for recurrent or metastatic esophageal cancer patients who refused or were intolerant to intravenous chemotherapyMedicine 2021; 100(51): e28126 doi: 10.1097/MD.0000000000028126
3
Juan Li, Rong Qiu, Yuanping Hu, Yuxiang Wang, Zhan Qi, Ming He, Yuekao Li, Luca Bertero. Postoperative Adjuvant Therapy for Patients with pN+ Esophageal Squamous Cell CarcinomaBioMed Research International 2021; 2021: 1 doi: 10.1155/2021/8571438
4
Dan Han, Jing Tian, Junfeng Zhao, Shaoyu Hao. Optimal Treatment Strategies for Resectable Locally Advanced Esophageal Squamous Cell Carcinoma: A Real-World Triple Cohort Analysis Using Propensity Score MatchingInternational Journal of General Medicine 2023; : 5467 doi: 10.2147/IJGM.S440270
5
Ming He, Zhan Qi, Rong Qiu, Yuanping Hu, Juan Li, Yuekao Li, Yuxiang Wang, Pierfrancesco Franco. Correlates of Long-Term Survival of Patients with pN+ Esophageal Squamous Cell Carcinoma after EsophagectomyJournal of Oncology 2021; 2021: 1 doi: 10.1155/2021/6675691
6
Chunyang Song, Shuchai Zhu, Jinrui Xu, Jingwei Su, Xueyuan Zhang, Wenzhao Deng, Xiaohan Zhao, Wenbin Shen. Patterns of failure and long-term outcome of postoperative radiotherapy on the survival of patients with pathological T3N0M0 esophageal cancerFrontiers in Surgery 2022; 9 doi: 10.3389/fsurg.2022.959568